VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
COO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
COOThe Cooper Companies, Inc.
$71.89$14.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

COO logoThe Cooper Companies, Inc.(COO)Earnings, Financials & Key Ratios

COO•NASDAQ
$71.89
38.4× P/E·Price updated Jul 7, 2026
SectorHealthcareIndustryMedical InstrumentsSub-IndustryDental and vision care devices
AboutThe Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.Show more
  • Revenue$4.09B+5.1%
  • EBITDA$1.11B+2.3%
  • Net Income$375M-4.4%
  • EPS (Diluted)1.87-4.6%
  • Gross Margin60.67%-9.0%
  • EBITDA Margin27.02%-2.6%
  • Operating Margin16.69%-7.9%
  • Net Margin9.16%-9.0%
  • ROE4.59%-8.5%

COO Price & Volume

The Cooper Companies, Inc. (COO) stock price & volume — 10-year historical chart

Loading chart...

Operational Volatility Challenges Consistent Revenue Growth Trajectory

Investment Thesis • Updated 2026Q2

VerdictNeutral
Growth:Stable
Profitability:Strained
Financial:Healthy
Cash Flow:Mixed
Primary Risk:Operating margin volatility

Key Thesis Takeaways

  • The Cooper Companies demonstrates resilient top-line growth, evidenced by a 7.9% year-over-year revenue increase in 2026Q2, yet faces significant headwinds from escalating SG&A expenses that resulted in a $31.0 million operating loss.
  • While the firm maintains a disciplined debt-to-equity ratio of 0.30, the concentration of $3.9 billion in goodwill and recent margin compression suggest that investors should monitor the sustainability of its competitive moat.
  • Future performance hinges on the company's ability to stabilize operating margins and improve cash conversion, which currently shows a concerning negative OCF/NI ratio of -2.35.

Verdict Logic

while the firm exhibits consistent 7.9% revenue growth, the recent swing to a $77.9 million net loss and a negative OCF/NI ratio of -2.35 suggest that fundamental earnings quality remains too volatile for a high-conviction entry.

COO Growth Metrics

The Cooper Companies, Inc. (COO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years8.58%
5 Years10.98%
3 Years7.35%
TTM6.09%

Profit CAGR

10 Years6.3%
5 Years9.48%
3 Years-0.95%
TTM-43.07%

EPS CAGR

10 Years-7.64%
5 Years-17.22%
3 Years-1.22%
TTM-42.63%

Return on Capital

10 Years7.22%
5 Years5.96%
3 Years5.86%
Last Year6.05%

COO Recent Earnings

The Cooper Companies, Inc. (COO) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 8/12 qtrs (67%)
Q3 2026Latest
Jun 4, 2026
Metric
Actual
Est
EPS
$1.21+10.0%
$1.10
Rev
$1.1B+2.6%
$1.1B
Q2 2026
Mar 5, 2026
Metric
Actual
Est
EPS
$1.10+6.8%
$1.03
Rev
$1.0B+0.0%
$1.0B
Q4 2025
Dec 4, 2025
Metric
Actual
Est
EPS
$1.15+3.6%
$1.11
Rev
$1.1B+0.4%
$1.1B
Q3 2025
Aug 27, 2025
Metric
Actual
Est
EPS
$1.10+2.8%
$1.07
Rev
$1.1B-0.3%
$1.1B
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q3 2026LatestJun 4, 2026
$1.21vs $1.10+10.0%
$1.1Bvs $1.1B+2.6%
Q2 2026Mar 5, 2026
$1.10vs $1.03+6.8%
$1.0Bvs $1.0B+0.0%
Q4 2025Dec 4, 2025
$1.15vs $1.11+3.6%
$1.1Bvs $1.1B+0.4%
Q3 2025Aug 27, 2025
$1.10vs $1.07+2.8%
$1.1Bvs $1.1B-0.3%
Based on last 12 quarters of dataView full earnings history →

Latest COO News

Recent stock market news and headlines for The Cooper Companies, Inc. (COO)

PYMNTS·1 day ago
SEC Names JPMorgan Veteran Paul Knight as COO

The Securities and Exchange Commission (SEC) is adding a new operations chief at a moment when the agency is trying to move faster on crypto, market structure and investor protection.

GuruFocus·5 days ago
The Cooper Companies Inc (COO) Shares Surge 3.1% -- What GF Score of 84 Tells Investors

On July 02, 2026, The Cooper Companies Inc (COO) shares rose 3.1% today, bringing the current price to $74.20. The stock has experienced a 52-week range of $58.

GlobeNewsWire·Jul 1, 2026
New Era Energy & Digital Announces Leadership Transition to Support Next Phase of Execution and Growth

Charlie Nelson appointed Chairman and CEO; Ted Warner named President, CFO and appointed to Board; José Rodriguez appointed COO Charlie Nelson appointed Chairman and CEO; Ted Warner named President, CFO and appointed to Board; José Rodriguez appointed COO

GlobeNewsWire·Jun 30, 2026
CooperCompanies Releases 2025 Corporate Sustainability Report with Scope 3 Emissions Disclosure

SAN RAMON, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, released today its 2025 Corporate Sustainability Report. The report showcases the company's commitment to people and planet, supported by expanded performance metrics and continued progress on sustainability priorities. A key milestone in this year's report is the company's first-time disclosure of Scope 3 greenhouse gas emissions, enhancing transparency and strengthening its sustainability reporting.

Zacks Investment Research·Jun 30, 2026
How COO Is Balancing Premium Lens Growth Against Asia-Pacific Risks?

COO's premium lens, myopia control and fertility momentum support growth, but Asia-Pacific weakness and margin pressure keep the outlook measured.

Peers Comparison

Key metrics vs top competitors for The Cooper Companies, Inc. (COO)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
COO logoCOOThe Cooper Companies, Inc.Current
$71.89$14.02B38.445.06%9.16%4.59%—
BLCO logoBLCOBausch + Lomb Corporation
$17.10$6.1B-16.766.47%-4.21%-3.37%—
EW logoEWEdwards Lifesciences Corporation
$94.82$54.6B51.8111.55%17.34%10.54%—
HSIC logoHSICHenry Schein, Inc.
$86.84$9.89B26.564.03%2.95%8.14%—
HOLX logoHOLXHologic, Inc.
$76.01$16.97B30.531.74%13.18%11.01%—
JNJ logoJNJJohnson & Johnson
$267.24$643.31B24.236.05%21.83%26.26%—

Compare COO vs Peers

The Cooper Companies, Inc. (COO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs BLCO

Most directly comparable listed peer for COO.

Scale Benchmark

vs JNJ

Larger-name benchmark to compare COO against a more recognizable public peer.

Peer Set

Compare Top 5

vs BLCO, EW, HSIC, HOLX

COO SEC Filings & Documents

The Cooper Companies, Inc. (COO) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Jun 4, 2026·SEC

Material company update

May 4, 2026·SEC

Material company update

Apr 8, 2026·SEC

10-K Annual Reports

4
FY 2025

Dec 5, 2025·SEC

FY 2024

Dec 6, 2024·SEC

FY 2023

Dec 8, 2023·SEC

10-Q Quarterly Reports

6
FY 2026

Jun 5, 2026·SEC

FY 2026

Mar 6, 2026·SEC

FY 2025

Aug 28, 2025·SEC

Get notified when COO posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

COO Frequently Asked Questions

The Cooper Companies, Inc. (COO) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is The Cooper Companies, Inc.'s revenue?

The Cooper Companies, Inc. (COO) reported $4.23B in revenue for fiscal year 2025. This represents a 3778% increase from $109.1M in 1996.

How fast is The Cooper Companies, Inc. growing?

The Cooper Companies, Inc. (COO) grew revenue by 5.1% over the past year. This is steady growth.

Is COO profitable?

Yes, The Cooper Companies, Inc. (COO) is profitable, generating $235.8M in net income for fiscal year 2025 (9.2% net margin).

Dividend & Returns
What is COO's return on equity?

The Cooper Companies, Inc. (COO) has a return on equity (ROE) of 4.6%. This is below average, suggesting room for improvement.

What is The Cooper Companies, Inc.'s free cash flow?

The Cooper Companies, Inc. (COO) generated $569.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in COO back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →